DR. VINCENT LOUIS ANGELONI, M.D.

CLIVE, IA

Research Active
Dermatology NPI registered 21+ years 23 publications 1998 – 2025 NPI: 1689671745
Cell Line, TumorBreast NeoplasmsComposite ResinsSurface PropertiesMaterials TestingDentinIn Vitro TechniquesDental BondingTensile StrengthMolar, ThirdResin CementsDentin-Bonding AgentsDental CementsAcid Etching, DentalCarbodiimides

Practice Location

12327 STRATFORD DR
CLIVE, IA 50325-8148

Phone: (515) 224-7088

What does VINCENT ANGELONI research?

Dr. Angeloni studies how different materials and chemicals can improve dental adhesives used in procedures like fillings and crowns. He explores various treatments that enhance the strength and longevity of these adhesives, using substances like chlorhexidine and carbodiimide to protect teeth from decay and ensure dental work lasts longer. Additionally, he investigates the mechanisms of cancer spread, focusing particularly on breast and ovarian cancer, to identify new targets for potential treatments.

Key findings

  • In a 2018 study, using a special chemical (EDC) improved the bond strength of dental adhesives by about 20% after one year, which helps prevent further tooth decay.
  • Research on a dental adhesive containing chlorhexidine found that it maintained better bond strength over time compared to those without it, helping to prolong the effectiveness of dental work.
  • A 2017 study showed that EDC reduced harmful enzyme activity by up to 90%, suggesting stronger and longer-lasting dental bonds.
  • Dr. Angeloni discovered that higher levels of the AF1q protein in ovarian cancer cells were linked to increased cell movement, indicating a potential target for new cancer treatments.
  • His investigations into circulating microRNAs highlighted significant inconsistencies, indicating that standard guidelines are needed for their use in cancer diagnostics.

Frequently asked questions

Does Dr. Angeloni study dental adhesives?
Yes, he focuses on how various materials and chemicals can enhance the strength and durability of dental adhesives.
What types of cancer does Dr. Angeloni research?
He studies breast and ovarian cancer, specifically looking at how they spread and potential new treatment targets.
How does Dr. Angeloni's work help patients?
His research improves dental treatments, making them last longer, and contributes to the understanding and potential treatment of cancer.
What materials has Dr. Angeloni tested in dental procedures?
He has tested materials like chlorhexidine and carbodiimide to improve the effectiveness of dental adhesives.
Is Dr. Angeloni's research relevant for cancer patients?
Yes, his work provides insights into how cancer spreads and identifies targets that may lead to better treatment options.

Publications in plain English

Correction: Exosome-mediated delivery of miR-9 induces cancer-associated fibroblast-like properties in human breast fibroblasts.

2025

Cell death & disease

Baroni S, Romero-Cordoba S, Plantamura I, Dugo M, D'Ippolito E +6 more

PubMed

Chronic kidney disease and SARS-CoV-2 outbreak: Lazio region organizational model.

2020

Clinical kidney journal

Dominijanni S, Foniciello M, Tatangelo P, Angeloni V, Londrino F +4 more

PubMed

Long-term bond strength and endogenous enzymatic activity of a chlorhexidine-containing commercially available adhesive.

2019

Journal of dentistry

Maravić T, Comba A, Cunha SR, Angeloni V, Cadenaro M +5 more

Plain English
This study looked at how a specific dental adhesive containing a substance called chlorhexidine (0.2% CHX) affects the strength of its bond to teeth over time and its ability to block certain enzymes. The researchers tested the adhesive on non-cavity teeth and found that the bond strength was stronger when chlorhexidine was included, both right after application and after a year in artificial saliva. However, the bond strength did reduce after 12 months, but the presence of chlorhexidine helped maintain better strength and inhibit harmful enzymes. Who this helps: This benefits dentists and their patients by improving the durability of dental adhesives used in treatments.

PubMed

Experimental use of an acrolein-based primer as collagen cross-linker for dentine bonding.

2018

Journal of dentistry

Maravic T, Breschi L, Comba A, Cunha SR, Angeloni V +5 more

Plain English
This study looked at whether a low concentration of acrolein (ACR) could help make dental bonds stronger and last longer when used as a primer before applying adhesive. Researchers found that using a 0.01% ACR solution helped maintain the strength of the bond between the tooth and adhesive over one year, without affecting the bond strength right after application. This is important because it could lead to dental work that lasts longer and requires fewer replacements. Who this helps: This benefits dental patients by potentially improving the durability of their dental treatments.

PubMed

Cross-linking effect on dentin bond strength and MMPs activity.

2018

Dental materials : official publication of the Academy of Dental Materials

Mazzoni A, Angeloni V, Comba A, Maravic T, Cadenaro M +4 more

Plain English
This study looked at how a special chemical (EDC) can improve the lasting strength of dental adhesives used on teeth and how it affects certain enzymes in dentin (the tissue under the tooth surface). Researchers tested 80 extracted molars and found that the EDC treatment did not change the immediate grip of the adhesives but significantly improved their bond strength after one year—showing a difference of about 20% stronger bonds. This matters because stronger and longer-lasting dental fillings can help prevent further tooth decay and improve dental care outcomes. Who this helps: This benefits patients receiving dental treatments.

PubMed

Effect of a one-step self-etch adhesive on endogenous dentin matrix metalloproteinases.

2017

European journal of oral sciences

Apolonio FM, Mazzoni A, Angeloni V, Scaffa PM, Santi S +4 more

Plain English
This study looked at how a specific dental adhesive called Adper Easy Bond affects certain enzymes in teeth that can break down the tooth's structure. The researchers found that after using this adhesive, the activity of two harmful enzymes, MMP-2 and MMP-9, actually increased, which means they could weaken the tooth's collagen over time. This matters because it suggests that while the adhesive might initially help bond the tooth, it could lead to problems later on by breaking down the tooth's natural fibers. Who this helps: Dentists and patients needing dental work.

PubMed

Involvement of AF1q/MLLT11 in the progression of ovarian cancer.

2017

Oncotarget

Tiberio P, Lozneanu L, Angeloni V, Cavadini E, Pinciroli P +7 more

Plain English
This study examined the role of a protein called AF1q in ovarian cancer. Researchers found that higher levels of AF1q in ovarian cancer cells led to increased movement and invasiveness of cancer cells, suggesting it helps tumors grow and spread. In tests, AF1q was absent in healthy ovarian tissue but present in cancerous tissues, and it was much lower in less aggressive tumors compared to aggressive ones. Who this helps: This helps patients with ovarian cancer by identifying a potential target for new treatments.

PubMed

Substantivity of Carbodiimide Inhibition on Dentinal Enzyme Activity over Time.

2017

Journal of dental research

Mazzoni A, Angeloni V, Sartori N, Duarte S, Maravic T +4 more

Plain English
This study looked at how a chemical called EDC affects the breakdown of collagen, which is important for the durability of dental bonds. Researchers found that using EDC significantly reduced the activity of enzymes that damage collagen after one year, especially with one type of bonding method (XP Bond), where the enzyme activity was much lower compared to untreated samples. This is important because it suggests that EDC can help maintain stronger dental bonds over time, potentially leading to longer-lasting dental repairs. Who this helps: Patients needing dental work.

PubMed

Role of Chlorhexidine on Long-term Bond Strength of Self-adhesive Composite Cements to Intraradicular Dentin.

2017

The journal of adhesive dentistry

Angeloni V, Mazzoni A, Marchesi G, Cadenaro M, Comba A +5 more

Plain English
This study looked at how a mouthwash ingredient called chlorhexidine (CHX) affects the strength of dental materials used to secure fiber posts in teeth over time. Researchers tested two types of cements with and without CHX, checking their bond strength right after applying them and then again after 6 months and 1 year. They discovered that while the bond strength decreased as time passed, using CHX did not make a significant difference in maintaining that strength. Who this helps: This benefits dentists and their patients by giving insights into the materials used for tooth restoration.

PubMed

Polyurethane foam scaffold as in vitro model for breast cancer bone metastasis.

2017

Acta biomaterialia

Angeloni V, Contessi N, De Marco C, Bertoldi S, Tanzi MC +2 more

Plain English
This study explored the use of a special foam to create a model that mimics how breast cancer spreads to bones. Researchers found that the foam effectively supports the growth and interaction of breast cancer cells with bone cells, which is important because it helps to understand how cancer spreads. This new model may lead to better insights into tumor behavior and the ways to combat cancer spread, moving beyond traditional research methods. Who this helps: This benefits patients and doctors by providing better tools for research into breast cancer treatments.

PubMed

Exosome-mediated delivery of miR-9 induces cancer-associated fibroblast-like properties in human breast fibroblasts.

2016

Cell death & disease

Baroni S, Romero-Cordoba S, Plantamura I, Dugo M, D'Ippolito E +6 more

Plain English
This study looked at how a specific microRNA called miR-9 influences normal breast cells to behave more like cancer-supporting cells, known as cancer-associated fibroblasts (CAFs). Researchers found that when miR-9 is increased in normal breast cells, these cells gain enhanced movement and invasion abilities, which contribute to tumor growth. Specifically, miR-9 levels were higher in CAFs from breast cancer patients compared to normal fibroblasts, and reducing miR-9 led to decreased tumor-promoting behaviors in these cells. Who this helps: This research benefits cancer patients and doctors by providing insights into how tumor growth might be targeted through the interactions between cancer cells and their surrounding environment.

PubMed

Duchenne muscular dystrophy caused by a frame-shift mutation in the acceptor splice site of intron 26.

2016

BMC medical genetics

Meregalli M, Maciotta S, Angeloni V, Torrente Y

Plain English
This study focused on a specific genetic mutation in a young boy that affects the dystrophin gene, which is crucial for muscle function. Researchers found that a change in the DNA led to a faulty production of the dystrophin protein, causing muscle weakness, which is characteristic of Duchenne muscular dystrophy. Understanding this mutation could help develop targeted treatments, such as antisense oligonucleotide therapies, to better manage this condition. Who this helps: This research benefits patients with Duchenne muscular dystrophy and their families.

PubMed

Implications of stemness-related signaling pathways in breast cancer response to therapy.

2015

Seminars in cancer biology

Angeloni V, Tiberio P, Appierto V, Daidone MG

Plain English
This study looked at a specific group of cells in breast cancer called breast cancer-initiating cells (BCICs), which can start and maintain tumors and resist current treatments. Researchers found that these cells could recreate tumors in mice even in very small amounts, and changes in certain genes related to these cells contribute to cancer growth. This research is important because it highlights new potential targets for treatments that could be more effective against difficult-to-treat breast cancers. Who this helps: This helps patients with breast cancer, especially those facing treatment resistance.

PubMed

Challenges in using circulating miRNAs as cancer biomarkers.

2015

BioMed research international

Tiberio P, Callari M, Angeloni V, Daidone MG, Appierto V

Plain English
This study looked at the use of tiny RNA molecules called circulating miRNAs as potential markers for diagnosing and monitoring cancer. Researchers found that while these miRNAs could be useful, there are significant inconsistencies in research results due to issues like how blood samples are collected and processed. Without clear guidelines and standard methods, the promise of using miRNAs in cancer care is at risk of being unproven. Who this helps: This research benefits doctors and researchers working on cancer detection and treatment.

PubMed

Proposal of supervised data analysis strategy of plasma miRNAs from hybridisation array data with an application to assess hemolysis-related deregulation.

2015

BMC bioinformatics

Landoni E, Miceli R, Callari M, Tiberio P, Appierto V +3 more

Plain English
This study looked at small RNA molecules in blood plasma, known as miRNAs, to see if they could help identify when blood samples have been damaged (hemolyzed). The researchers developed a new method to analyze the data and found five specific miRNAs that were more active in hemolyzed samples. This is important because it provides a way to detect damaged blood samples, ensuring more accurate tests and treatments for patients. Who this helps: This helps doctors and medical laboratories in accurately assessing blood samples.

PubMed

Carbodiimide inactivation of MMPs and effect on dentin bonding.

2014

Journal of dental research

Mazzoni A, Apolonio FM, Saboia VP, Santi S, Angeloni V +6 more

Plain English
This study looked at how a chemical called EDC can stop certain enzymes in dentin (the tissue in teeth) from breaking down dental adhesives. Researchers found that using EDC before applying the adhesives reduced enzyme activity significantly—up to 90% less activity compared to samples without EDC. This is important because it could lead to stronger and longer-lasting dental bonds, improving the success of dental procedures. Who this helps: Patients receiving dental treatments.

PubMed

Effect of carbodiimide (EDC) on the bond stability of etch-and-rinse adhesive systems.

2013

Dental materials : official publication of the Academy of Dental Materials

Mazzoni A, Angeloni V, Apolonio FM, Scotti N, Tjäderhane L +5 more

Plain English
This study investigated how a chemical called EDC affects the durability of dental adhesives used to bond teeth. Researchers found that while using EDC didn’t change the immediate adhesion strength, it significantly helped maintain the bond over one year, preserving strength by about 5% better than adhesives without EDC. This is important because it suggests that EDC can help keep dental work durable for longer, potentially reducing the need for repeat procedures. Who this helps: This benefits dentists and their patients by improving the longevity of dental restorations.

PubMed

Expression of CD20 reveals a new store-operated calcium entry modulator in skeletal muscle.

2012

The international journal of biochemistry & cell biology

Parolini D, Cassinelli L, Razini P, Sitzia C, Tonna N +12 more

Plain English
This study looked at a protein called CD20 and its role in how calcium enters skeletal muscle cells, which is important for muscle function and development. The researchers found that blocking CD20 in muscle cells led to a significant decrease in calcium entry, indicating that CD20 is crucial for this process. Understanding how CD20 affects calcium entry could help improve treatments for muscle-related disorders. Who this helps: This helps patients with muscle disorders and healthcare professionals working in muscle physiology.

PubMed

Primary cell cultures from human renal cortex and renal-cell carcinoma evidence a differential expression of two spliced isoforms of Annexin A3.

2010

The American journal of pathology

Bianchi C, Bombelli S, Raimondo F, Torsello B, Angeloni V +11 more

Plain English
This study examined kidney cells from both healthy tissue and cancerous renal cell carcinoma (RCC) in 60 patients to understand the behavior of a protein called Annexin A3. Researchers found that in cancer cells, a specific version of Annexin A3 was lower (36 kDa protein), while another version was higher (33 kDa protein), suggesting a link between these changes and cancer growth. The way Annexin A3 is expressed in normal versus cancerous renal cells could lead to new strategies for managing RCC. Who this helps: This research benefits patients with renal cell carcinoma by potentially informing new treatment approaches.

PubMed

Two cases of ascending peritonitis in CAPD.

2010

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis

Rocca AR, Esposto C, Utzeri G, Angeloni V, Capece R +2 more

PubMed

Concentration and microsatellite status of plasma DNA for monitoring patients with renal carcinoma.

2008

European journal of cancer (Oxford, England : 1990)

Perego RA, Corizzato M, Brambilla P, Ferrero S, Bianchi C +12 more

Plain English
This study looked at the levels of DNA in the blood of patients with kidney cancer (renal cell carcinoma) before and after surgery. Researchers found that the concentration of plasma DNA was much higher in patients with cancer (an average of 26.4 ng/ml) compared to healthy controls (3.2 ng/ml). They also found changes in DNA patterns that could predict when the cancer might return, highlighting the importance of monitoring these levels over time for better patient outcomes. Who this helps: This benefits patients with kidney cancer and their doctors by providing a way to monitor for possible cancer recurrence.

PubMed

Eight full-length abelson related gene (Arg) isoforms are constitutively expressed in caki-1 cell line and cell distribution of two isoforms has been analyzed after transfection.

2008

Journal of cellular biochemistry

Bianchi C, Torsello B, Angeloni V, Bombelli S, Soldi M +3 more

Plain English
This study examined eight different forms of the Arg protein in Caki-1 cells, a type of kidney cancer cell line. Researchers found that all eight forms are actively produced in these cells, with some showing different locations and behaviors within the cells. This matters because understanding how these Arg protein forms interact with cell structures could provide insights into their roles in healthy and cancerous cells, potentially leading to new treatments. Who this helps: This helps patients by advancing cancer research and treatment options.

PubMed

Bullous pemphigoid in a previously irradiated site.

1998

Cutis

Clayton AS, Angeloni V

Plain English
This study looked at a 58-year-old woman who developed a skin condition called bullous pemphigoid after receiving radiation therapy for breast cancer. The condition mainly affected the area that was treated with radiation. She recovered fully within a few weeks after taking two medications, tetracycline and niacinamide, together. Who this helps: This information is valuable for doctors treating patients with similar backgrounds and conditions.

PubMed

Frequent Co-Authors

Lorenzo Breschi Annalisa Mazzoni Maria Grazia Daidone Allegra Comba David H Pashley Franklin R Tay Paola Tiberio Valentina Appierto Milena Cadenaro Maurizio Callari

Physician data sourced from the NPPES NPI Registry . Publication data from PubMed . Plain-English summaries generated by AI. Not medical advice.